162 related articles for article (PubMed ID: 31190799)
1. Biodistribution and sensitive tracking of immune cells with plasmonic gold nanostars.
Liu Y; Huang W; Xiong C; Huang Y; Chen BJ; Racioppi L; Chao N; Vo-Dinh T
Int J Nanomedicine; 2019; 14():3403-3411. PubMed ID: 31190799
[No Abstract] [Full Text] [Related]
2. Cellular Uptake and Tissue Biodistribution of Functionalized Gold Nanoparticles and Nanoclusters.
Escudero-Francos MA; Cepas V; González-Menédez P; Badía-Laíño R; Díaz-García ME; Sainz RM; Mayo JC; Hevia D
J Biomed Nanotechnol; 2017 Feb; 13(2):167-79. PubMed ID: 29377647
[TBL] [Abstract][Full Text] [Related]
3. Quantitative biokinetics and systemic translocation of various gold nanostructures are highly dependent on their size and shape.
Zhang J; Nie X; Ji Y; Liu Y; Wu X; Chen C; Fang X
J Nanosci Nanotechnol; 2014 Jun; 14(6):4124-38. PubMed ID: 24738361
[TBL] [Abstract][Full Text] [Related]
4. Tracking mesenchymal stromal cells using an ultra-bright TAT-functionalized plasmonic-active nanoplatform.
Yuan H; Gomez JA; Chien JS; Zhang L; Wilson CM; Li S; Fales AM; Liu Y; Grant GA; Mirotsou M; Dzau VJ; Vo-Dinh T
J Biophotonics; 2016 Apr; 9(4):406-13. PubMed ID: 27095616
[TBL] [Abstract][Full Text] [Related]
5. Gold nanostars coated with neutral and charged polyethylene glycols: A comparative study of in-vitro biocompatibility and of their interaction with SH-SY5Y neuroblastoma cells.
Pallavicini P; Cabrini E; Cavallaro G; Chirico G; Collini M; D'Alfonso L; Dacarro G; Donà A; Marchesi N; Milanese C; Pascale A; Sironi L; Taglietti A
J Inorg Biochem; 2015 Oct; 151():123-31. PubMed ID: 25997575
[TBL] [Abstract][Full Text] [Related]
6. Oral pH sensitive GNS@ab nanoprobes for targeted therapy of Helicobacter pylori without disturbance gut microbiome.
Zhi X; Liu Y; Lin L; Yang M; Zhang L; Zhang L; Liu Y; Alfranca G; Ma L; Zhang Q; Fu H; Conde J; Ding X; Chen D; Ni J; Song J; Cui D
Nanomedicine; 2019 Aug; 20():102019. PubMed ID: 31125676
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.
Sonavane G; Tomoda K; Makino K
Colloids Surf B Biointerfaces; 2008 Oct; 66(2):274-80. PubMed ID: 18722754
[TBL] [Abstract][Full Text] [Related]
8. Protracted elimination of gold nanoparticles from mouse liver.
Sadauskas E; Danscher G; Stoltenberg M; Vogel U; Larsen A; Wallin H
Nanomedicine; 2009 Jun; 5(2):162-9. PubMed ID: 19217434
[TBL] [Abstract][Full Text] [Related]
9. Gold nanostars for efficient in vitro and in vivo real-time SERS detection and drug delivery via plasmonic-tunable Raman/FTIR imaging.
Tian F; Conde J; Bao C; Chen Y; Curtin J; Cui D
Biomaterials; 2016 Nov; 106():87-97. PubMed ID: 27552319
[TBL] [Abstract][Full Text] [Related]
10. Evaluating cellular uptake of gold nanoparticles in HL-7702 and HepG2 cells for plasmonic photothermal therapy.
Wang P; Wu Q; Wang F; Zhang Y; Tong L; Jiang T; Gu C; Huang S; Wang H; Bu S; Zhou J
Nanomedicine (Lond); 2018 Sep; 13(18):2245-2259. PubMed ID: 30280957
[TBL] [Abstract][Full Text] [Related]
11. Targeted Delivery of siRNA with pH-Responsive Hybrid Gold Nanostars for Cancer Treatment.
Zhu H; Liu W; Cheng Z; Yao K; Yang Y; Xu B; Su G
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937584
[TBL] [Abstract][Full Text] [Related]
12. Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors.
Lara P; Palma-Florez S; Salas-Huenuleo E; Polakovicova I; Guerrero S; Lobos-Gonzalez L; Campos A; Muñoz L; Jorquera-Cordero C; Varas-Godoy M; Cancino J; Arias E; Villegas J; Cruz LJ; Albericio F; Araya E; Corvalan AH; Quest AFG; Kogan MJ
J Nanobiotechnology; 2020 Jan; 18(1):20. PubMed ID: 31973696
[TBL] [Abstract][Full Text] [Related]
13. Gold nanostars co-coated with the Cu(II) complex of a tetraazamacrocyclic ligand.
Pallavicini P; Bernhard C; Chirico G; Dacarro G; Denat F; Donà A; Milanese C; Taglietti A
Dalton Trans; 2015 Mar; 44(12):5652-61. PubMed ID: 25708886
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of reduced-size gold nanostars and internalization in SH-SY5Y cells.
Dacarro G; Pallavicini P; Bertani SM; Chirico G; D'Alfonso L; Falqui A; Marchesi N; Pascale A; Sironi L; Taglietti A; Zuddas E
J Colloid Interface Sci; 2017 Nov; 505():1055-1064. PubMed ID: 28697545
[TBL] [Abstract][Full Text] [Related]
15. Gold Nanostars: A Novel Platform for Developing
Liu Y; Zhou Z; Feng Y; Zhao XG; Vaidyanathan G; Zalutsky MR; Vo-Dinh T
Int J Nanomedicine; 2021; 16():7297-7305. PubMed ID: 34737567
[TBL] [Abstract][Full Text] [Related]
16. Shape dependence of gold nanoparticles on in vivo acute toxicological effects and biodistribution.
Sun YN; Wang CD; Zhang XM; Ren L; Tian XH
J Nanosci Nanotechnol; 2011 Feb; 11(2):1210-6. PubMed ID: 21456161
[TBL] [Abstract][Full Text] [Related]
17. Caged gold nanostars: a novel plasmonic nanoplatform with potential theranostic applications.
Canning AJ; Vo-Dinh T
Nanoscale; 2024 May; 16(18):8828-8835. PubMed ID: 38572521
[TBL] [Abstract][Full Text] [Related]
18. Gold nanostars-diagnosis, bioimaging and biomedical applications.
Mousavi SM; Zarei M; Hashemi SA; Ramakrishna S; Chiang WH; Lai CW; Gholami A
Drug Metab Rev; 2020 May; 52(2):299-318. PubMed ID: 32150480
[TBL] [Abstract][Full Text] [Related]
19. In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars.
Nie L; Wang S; Wang X; Rong P; Ma Y; Liu G; Huang P; Lu G; Chen X
Small; 2014 Apr; 10(8):1585-93, 1441. PubMed ID: 24150920
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe.
Liu Y; Carpenter AB; Pirozzi CJ; Yuan H; Waitkus MS; Zhou Z; Hansen L; Seywald M; Odion R; Greer PK; Hawk T; Chin BB; Vaidyanathan G; Zalutsky MR; Yan H; Vo-Dinh T
Nanotechnology; 2019 Jul; 30(27):275101. PubMed ID: 30856613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
